Metraipolis › archive › dc_ce9fedf7ff4c

CAR-T cell therapies in autoimmune rheumatic diseases: a brief report on the clinical trial landscape, current status, and future perspectives — Europe PMC PMID:41200159

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41200159
DOI
10.3389/fimmu.2025.1630569
License (as archived)
solo-consultazione
Archived
2026-11-09T04:04:28.660Z
SHA-256 of the archived text
73c65088fa5c78f9b3dfad9113ab4e8e1cab447df9423e4b5998d4d2e7fd2054
Stable URL of this page
https://metraipolis.com/documento/dc_ce9fedf7ff4c

How to cite

CAR-T cell therapies in autoimmune rheumatic diseases: a brief report on the clinical trial landscape, current status, and future perspectives — Europe PMC PMID:41200159 — Europe PMC (en), https://europepmc.org/article/MED/41200159 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce9fedf7ff4c (Metraipolis archive dc_ce9fedf7ff4c, sha256 73c65088fa5c78f9b3dfad9113ab4e8e1cab447df9423e4b5998d4d2e7fd2054)
BibTeX
@misc{dcce9fedf7ff4c,
  title = {CAR-T cell therapies in autoimmune rheumatic diseases: a brief report on the clinical trial landscape, current status, and future perspectives — Europe PMC PMID:41200159},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41200159},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce9fedf7ff4c; sha256 73c65088fa5c78f9b3dfad9113ab4e8e1cab447df9423e4b5998d4d2e7fd2054},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41200159. Agents can read the archived copy with the MCP tool read_document.